Cargando…

[(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery

PURPOSE: Medullary thyroid carcinoma (MTC) is characterized by a high rate of metastasis. In this study we evaluated the ability of [(18)F]DOPA PET/ceCT to stage MTC in patients with suspicious thyroid nodules and pathologically elevated serum calcitonin (Ctn) levels prior to total thyroidectomy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasul, Sazan, Hartenbach, Sabrina, Rebhan, Katharina, Göllner, Adelina, Karanikas, Georgios, Mayerhoefer, Marius, Mazal, Peter, Hacker, Marcus, Hartenbach, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182401/
https://www.ncbi.nlm.nih.gov/pubmed/29766245
http://dx.doi.org/10.1007/s00259-018-4045-9
_version_ 1783362554934853632
author Rasul, Sazan
Hartenbach, Sabrina
Rebhan, Katharina
Göllner, Adelina
Karanikas, Georgios
Mayerhoefer, Marius
Mazal, Peter
Hacker, Marcus
Hartenbach, Markus
author_facet Rasul, Sazan
Hartenbach, Sabrina
Rebhan, Katharina
Göllner, Adelina
Karanikas, Georgios
Mayerhoefer, Marius
Mazal, Peter
Hacker, Marcus
Hartenbach, Markus
author_sort Rasul, Sazan
collection PubMed
description PURPOSE: Medullary thyroid carcinoma (MTC) is characterized by a high rate of metastasis. In this study we evaluated the ability of [(18)F]DOPA PET/ceCT to stage MTC in patients with suspicious thyroid nodules and pathologically elevated serum calcitonin (Ctn) levels prior to total thyroidectomy and lymph node (LN) dissection. METHODS: A group of 32 patients with sonographically suspicious thyroid nodules and pathologically elevated basal Ctn (bCtn) and stimulated Ctn (sCtn) levels underwent DOPA PET/ceCT prior to surgery. Postoperative histology served as the standard of reference for ultrasonography and DOPA PET/ceCT region-based LN staging. Univariate and multivariate regression analyses as well as receiver operating characteristic analysis were used to evaluate the correlations between preoperative and histological parameters and postoperative tumour persistence or relapse. RESULTS: Primary MTC was histologically verified in all patients. Of the 32 patients, 28 showed increased DOPA decarboxylase activity in the primary tumour (sensitivity 88%, mean SUVmax 10.5). Undetected tumours were exclusively staged pT1a. The sensitivities of DOPA PET in the detection of central and lateral metastatic neck LN were 53% and 73%, in contrast to 20% and 39%, respectively, for neck ultrasonography. Preoperative bCtn and carcinoembryonic antigen levels as well as cN1b status and the number of involved neck regions on DOPA PET/ceCT were predictive of postoperative tumour persistence/relapse in the univariate regression analysis (P < 0.05). Only DOPA PET/ceCT cN1b status remained significant in the multivariate analysis (P = 0.016, relative risk 4.02). CONCLUSION: This study revealed that DOPA PET/ceCT has high sensitivity in the detection of primary MTC and superior sensitivity in the detection of LN metastases compared to ultrasonography. DOPA PET/ceCT identification of N1b status predicts postoperative tumour persistence. Thus, implementation of a DOPA-guided LN dissection might improve surgical success.
format Online
Article
Text
id pubmed-6182401
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-61824012018-10-22 [(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery Rasul, Sazan Hartenbach, Sabrina Rebhan, Katharina Göllner, Adelina Karanikas, Georgios Mayerhoefer, Marius Mazal, Peter Hacker, Marcus Hartenbach, Markus Eur J Nucl Med Mol Imaging Original Article PURPOSE: Medullary thyroid carcinoma (MTC) is characterized by a high rate of metastasis. In this study we evaluated the ability of [(18)F]DOPA PET/ceCT to stage MTC in patients with suspicious thyroid nodules and pathologically elevated serum calcitonin (Ctn) levels prior to total thyroidectomy and lymph node (LN) dissection. METHODS: A group of 32 patients with sonographically suspicious thyroid nodules and pathologically elevated basal Ctn (bCtn) and stimulated Ctn (sCtn) levels underwent DOPA PET/ceCT prior to surgery. Postoperative histology served as the standard of reference for ultrasonography and DOPA PET/ceCT region-based LN staging. Univariate and multivariate regression analyses as well as receiver operating characteristic analysis were used to evaluate the correlations between preoperative and histological parameters and postoperative tumour persistence or relapse. RESULTS: Primary MTC was histologically verified in all patients. Of the 32 patients, 28 showed increased DOPA decarboxylase activity in the primary tumour (sensitivity 88%, mean SUVmax 10.5). Undetected tumours were exclusively staged pT1a. The sensitivities of DOPA PET in the detection of central and lateral metastatic neck LN were 53% and 73%, in contrast to 20% and 39%, respectively, for neck ultrasonography. Preoperative bCtn and carcinoembryonic antigen levels as well as cN1b status and the number of involved neck regions on DOPA PET/ceCT were predictive of postoperative tumour persistence/relapse in the univariate regression analysis (P < 0.05). Only DOPA PET/ceCT cN1b status remained significant in the multivariate analysis (P = 0.016, relative risk 4.02). CONCLUSION: This study revealed that DOPA PET/ceCT has high sensitivity in the detection of primary MTC and superior sensitivity in the detection of LN metastases compared to ultrasonography. DOPA PET/ceCT identification of N1b status predicts postoperative tumour persistence. Thus, implementation of a DOPA-guided LN dissection might improve surgical success. Springer Berlin Heidelberg 2018-05-15 2018 /pmc/articles/PMC6182401/ /pubmed/29766245 http://dx.doi.org/10.1007/s00259-018-4045-9 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Rasul, Sazan
Hartenbach, Sabrina
Rebhan, Katharina
Göllner, Adelina
Karanikas, Georgios
Mayerhoefer, Marius
Mazal, Peter
Hacker, Marcus
Hartenbach, Markus
[(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
title [(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
title_full [(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
title_fullStr [(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
title_full_unstemmed [(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
title_short [(18)F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
title_sort [(18)f]dopa pet/cect in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182401/
https://www.ncbi.nlm.nih.gov/pubmed/29766245
http://dx.doi.org/10.1007/s00259-018-4045-9
work_keys_str_mv AT rasulsazan 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT hartenbachsabrina 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT rebhankatharina 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT gollneradelina 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT karanikasgeorgios 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT mayerhoefermarius 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT mazalpeter 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT hackermarcus 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery
AT hartenbachmarkus 18fdopapetcectindiagnosisandstagingofprimarymedullarythyroidcarcinomapriortosurgery